RXST Insider Trading

Insider Ownership Percentage: 9.36%
Insider Buying (Last 12 Months): $549,098.81
Insider Selling (Last 12 Months): $9,651,106.44

RxSight Insider Trading History Chart

This chart shows the insider buying and selling history at RxSight by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$45kbought$109ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

RxSight Share Price & Price History

Current Price: $29.81
Price Change: Price Decrease of -2.06 (-6.46%)
As of 02/14/2025 05:00 PM ET

This chart shows the closing price history over time for RXST up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarAprMayJunJulAugSepOctNovDecJanFeb$29.81Closing price on 02/14/25:

SEC Filings (Institutional Ownership Changes) for RxSight (NASDAQ:RXST)

78.78% of RxSight stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RXST by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$81Mbought$70MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50M$0$50MTotal InflowsTotal Outflows
RxSight logo
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Read More on RxSight

Today's Range

Now: $29.81
Low: $29.65
High: $32.25

50 Day Range

MA: $33.91
Low: $29.81
High: $39.68

52 Week Range

Now: $29.81
Low: $26.29
High: $66.54

Volume

597,816 shs

Average Volume

670,931 shs

Market Capitalization

$1.20 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of RxSight?

RxSight's top insider shareholders include:
  1. Bakker Juliet Tammenoms (Director)
  2. Ronald M Md Kurtz (CEO)
  3. Jesse Anderson Corley (Director)
  4. Eric Weinberg (Insider)
  5. Ilya Goldshleger (Insider)
  6. Julie Andrews (Director)
  7. Robert Keith Warner (Director)
  8. Ilya Goldshleger (COO)
  9. Shweta Maniar (Director)
  10. William J Phd Link (Director)
  11. Shelley B Thunen (CFO)
Learn More about top insider investors at RxSight.

Who are the major institutional investors of RxSight?

RxSight's top institutional investors include:
  1. RA Capital Management L.P. — 9.29%
  2. Vanguard Group Inc. — 5.91%
  3. Artisan Partners Limited Partnership — 3.85%
  4. Geode Capital Management LLC — 2.06%
  5. Gilder Gagnon Howe & Co. LLC — 1.06%
  6. DF Dent & Co. Inc. — 1.05%
Learn More about top institutional investors of RxSight stock.

Which major investors are selling RxSight stock?

During the previous quarter, RXST stock was sold by these institutional investors:
  1. Invesco Ltd.
  2. Next Century Growth Investors LLC
  3. RA Capital Management L.P.
  4. Gilder Gagnon Howe & Co. LLC
  5. JPMorgan Chase & Co.
  6. American Century Companies Inc.
  7. Oberweis Asset Management Inc.
  8. Walleye Capital LLC
In the previous year, company insiders that have sold RxSight company stock include:
  1. Bakker Juliet Tammenoms (Director)
  2. Ronald M Md Kurtz (CEO)
  3. Jesse Anderson Corley (Director)
  4. Eric Weinberg (Insider)
  5. Ilya Goldshleger (Insider)
Learn More investors selling RxSight stock.

Which major investors are buying RxSight stock?

In the previous quarter, RXST stock was acquired by institutional investors including:
  1. DF Dent & Co. Inc.
  2. Artisan Partners Limited Partnership
  3. Dimensional Fund Advisors LP
  4. Schonfeld Strategic Advisors LLC
  5. Renaissance Technologies LLC
  6. Altium Capital Management LLC
  7. Vitruvian Partners LLP
  8. Thrivent Financial for Lutherans
During the previous year, these company insiders have bought RxSight stock:
  1. Bakker Juliet Tammenoms (Director)
  2. Ronald M Md Kurtz (CEO)
Learn More investors buying RxSight stock.